Survey with prize
You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on Human Metabolome Database.
Record Information
StatusDetected and Quantified
Creation Date2006-08-14 00:30:47 UTC
Update Date2020-04-22 23:32:26 UTC
Secondary Accession Numbers
  • HMDB04688
Metabolite Identification
Common NameHepoxilin A3
DescriptionHepoxilin A3 is an electrophilic eicosanoids synthesized during arachidonic acid oxidative metabolism, which can participate in the Michael addition reaction with glutathione (GSH, a major cellular antioxidant) catalyzed by the GSH-S-transferase (GST) family. GSH-adducts have been observed with molecules synthesized through the 12-lipoxygenase pathway. (PMID 12432937 ). Hepoxilins have biological actions that appear to have, as their basis, changes in intracellular concentrations of ions including calcium and potassium ions as well as changes in second messenger systems. Recent evidence suggests that the biological actions of the hepoxilins may be receptor-mediated as indicated from data showing the existence of hepoxilin-specific binding proteins in the human neutrophils. Such evidence also implicates the association of G-proteins both in hepoxilin-binding as well as in hepoxilin action. (PMID 7947989 ).
(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyeicosa-5,9,14-trienoic acidChEBI
8-Hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acidHMDB
Hexophilin a3HMDB
Hepoxilin aHMDB
(5Z,9E)-8-Hydroxy-10-{(2S,3S)-3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,9-dienoic acidHMDB
(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyeicosa-5,9,14-trienoic acidHMDB
(5Z,9E,14Z)-(11S,12S)-11,12-Epoxy-8-hydroxyicosa-5,9,14-trienoic acidHMDB
8-Hydroxy-11S,12S-epoxy-5Z,14Z,9E-eicosatrienoic acidHMDB
Hepoxilin a3MeSH
Chemical FormulaC20H32O4
Average Molecular Weight336.4657
Monoisotopic Molecular Weight336.230059512
IUPAC Name(5Z,9E)-8-hydroxy-10-[(2R,3S)-3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl]deca-5,9-dienoic acid
Traditional NameHXA3 cpd
CAS Registry Number85589-24-8
InChI Identifier
Chemical Taxonomy
Description belongs to the class of organic compounds known as hepoxilins. These are eicosanoids containing an oxirane group attached to the fatty acyl chain.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassEicosanoids
Direct ParentHepoxilins
Alternative Parents
  • Hepoxilin
  • Medium-chain hydroxy acid
  • Medium-chain fatty acid
  • Epoxy fatty acid
  • Heterocyclic fatty acid
  • Hydroxy fatty acid
  • Fatty acid
  • Unsaturated fatty acid
  • Secondary alcohol
  • Carboxylic acid derivative
  • Carboxylic acid
  • Dialkyl ether
  • Oxirane
  • Ether
  • Oxacycle
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Organic oxide
  • Hydrocarbon derivative
  • Carbonyl group
  • Alcohol
  • Organic oxygen compound
  • Organooxygen compound
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External Descriptors

Route of exposure:


Biological location:


Naturally occurring process:


Industrial application:

Biological role:

Physical Properties
Experimental Properties
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
Water Solubility0.0094 g/LALOGPS
pKa (Strongest Acidic)4.68ChemAxon
pKa (Strongest Basic)-2.9ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area70.06 ŲChemAxon
Rotatable Bond Count14ChemAxon
Refractivity99.72 m³·mol⁻¹ChemAxon
Polarizability38.57 ųChemAxon
Number of Rings1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-02vi-8693000000-2485293cd435c17c3c1cSpectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (2 TMS) - 70eV, Positivesplash10-00fs-9504200000-b478b5ac38b9ea248120Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-014i-0119000000-f183a896d40b122d34a6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-0100-3912000000-8c6e6837752424382cf9Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-05tf-9320000000-fd16a39bb680bae04d1eSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-000i-0029000000-babbe7e5cbfec6729e52Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-014r-1849000000-46fca9cc7712fb3e7876Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-0a4l-9510000000-19c94ffaa2521c24fe09Spectrum
Biological Properties
Cellular Locations
  • Extracellular
  • Membrane (predicted from logP)
Biospecimen Locations
  • Blood
Tissue Locations
  • Epidermis
  • Leukocyte
Normal Concentrations
BloodDetected and Quantified0.000114 +/- 0.000087 uMAdult (>18 years old)Both
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB023406
KNApSAcK IDNot Available
Chemspider ID4573947
KEGG Compound IDC14808
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkHepoxilin
PubChem Compound5460414
PDB IDNot Available
ChEBI ID15631
Food Biomarker OntologyNot Available
VMH IDNot Available
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Savidge TC, Newman PG, Pan WH, Weng MQ, Shi HN, McCormick BA, Quaroni A, Walker WA: Lipopolysaccharide-induced human enterocyte tolerance to cytokine-mediated interleukin-8 production may occur independently of TLR-4/MD-2 signaling. Pediatr Res. 2006 Jan;59(1):89-95. Epub 2005 Dec 2. [PubMed:16326999 ]
  2. Sutherland M, Schewe T, Nigam S: Biological actions of the free acid of hepoxilin A3 on human neutrophils. Biochem Pharmacol. 2000 Feb 15;59(4):435-40. [PubMed:10644052 ]
  3. Demin PM, Reynaud D, Pace-Asciak CR: Chemical synthesis and actions of 11,12-thiirano-hepoxilin A3. J Lipid Mediat Cell Signal. 1996 Jan;13(1):63-72. [PubMed:8998598 ]
  4. Murphy RC, Zarini S: Glutathione adducts of oxyeicosanoids. Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:471-82. [PubMed:12432937 ]
  5. Mills L, Reynaud D, Pace-Asciak CR: Hepoxilin-evoked intracellular reorganization of calcium in human neutrophils: a confocal microscopy study. Exp Cell Res. 1997 Feb 1;230(2):337-41. [PubMed:9024792 ]
  6. Pace-Asciak CR, Reynaud D, Laneuville O, Grinstein S, Nigam S: Hepoxilin A3 inhibits agonist-evoked rise in free intracellular calcium in human neutrophils. Adv Exp Med Biol. 1997;400A:375-80. [PubMed:9547579 ]
  7. Mrsny RJ, Gewirtz AT, Siccardi D, Savidge T, Hurley BP, Madara JL, McCormick BA: Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc Natl Acad Sci U S A. 2004 May 11;101(19):7421-6. Epub 2004 May 3. [PubMed:15123795 ]
  8. Nigam S, Patabhiraman S, Ciccoli R, Ishdorj G, Schwarz K, Petrucev B, Kuhn H, Haeggstrom JZ: The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity. J Biol Chem. 2004 Jul 9;279(28):29023-30. Epub 2004 May 3. [PubMed:15123652 ]
  9. Reynaud D, Demin PM, Sutherland M, Nigam S, Pace-Asciak CR: Hepoxilin signaling in intact human neutrophils: biphasic elevation of intracellular calcium by unesterified hepoxilin A3. FEBS Lett. 1999 Mar 12;446(2-3):236-8. [PubMed:10100848 ]
  10. Yu Z, Schneider C, Boeglin WE, Marnett LJ, Brash AR: The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9162-7. Epub 2003 Jul 24. [PubMed:12881489 ]
  11. Anton R, Puig L, Esgleyes T, de Moragas JM, Vila L: Occurrence of hepoxilins and trioxilins in psoriatic lesions. J Invest Dermatol. 1998 Apr;110(4):303-10. [PubMed:9540966 ]
  12. Pace-Asciak CR, Reynaud D, Rounova O, Demin P, Pivnitsky KK: Hepoxilin A3 is metabolized into its omega-hydroxy metabolite by human neutrophils. Adv Exp Med Biol. 1999;469:535-8. [PubMed:10667379 ]
  13. Dho S, Grinstein S, Corey EJ, Su WG, Pace-Asciak CR: Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils. Biochem J. 1990 Feb 15;266(1):63-8. [PubMed:2106877 ]
  14. Hurley BP, Siccardi D, Mrsny RJ, McCormick BA: Polymorphonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3. J Immunol. 2004 Nov 1;173(9):5712-20. [PubMed:15494523 ]
  15. Nigam S, Nodes S, Cichon G, Corey EJ, Pace-Asciak CR: Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils. Biochem Biophys Res Commun. 1990 Sep 28;171(3):944-8. [PubMed:2171511 ]
  16. Reynaud D, Rounova O, Demin PM, Pivnitsky KK, Pace-Asciak CR: Hepoxilin A3 is oxidized by human neutrophils into its omega-hydroxy metabolite by an activity independent of LTB4 omega-hydroxylase. Biochim Biophys Acta. 1997 Oct 18;1348(3):287-98. [PubMed:9366245 ]
  17. Pace-Asciak CR: Hepoxilins: a review on their cellular actions. Biochim Biophys Acta. 1994 Nov 17;1215(1-2):1-8. [PubMed:7947989 ]